Drug Approval | March 04, 2023
Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection
Rocuronium Bromide Injection is a neuromuscular blocking agent
Rocuronium Bromide Injection is a neuromuscular blocking agent
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Twelve hospitals across India will be part of the network which will support the trial in India
Clinical studies are expected to start in Q2 2023.
Ayurveda is one of the most advanced sciences of its times
Technology and innovation play a pivotal role towards enhancing healthcare systems, increasing access to healthcare services, and reducing costs of therapies and consultations
The players and management of Mumbai City FC presented patients with exclusive gifts, symbolizing support and appreciation for their fight against cancer
Experts’ conclave to pave holistic approach to cancer management
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
Subscribe To Our Newsletter & Stay Updated
